Symbol="CABA"
AssetType="Common Stock"
Name="Cabaletta Bio Inc"
Description="Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of T-cell therapies designed for patients with B-cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania."
CIK="1759138"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="507279000"
EBITDA="-56772000"
PERatio="None"
PEGRatio="None"
BookValue="2.924"
DividendPerShare="0"
DividendYield="0"
EPS="-1.78"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.335"
ReturnOnEquityTTM="-0.563"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.311"
EVToRevenue="-"
EVToEBITDA="-2.221"
Beta="2.564"
num_52WeekHigh="14.45"
num_52WeekLow="0.59"
num_50DayMovingAverage="12.13"
num_200DayMovingAverage="8.59"
SharesOutstanding="39693200"
DividendDate="None"
ExDividendDate="None"
symbol="CABA"
open="12.07"
high="13.11"
low="11.89"
price="12.78"
volume="387292.00"
latest_trading_day="2023-07-28"
previous_close="11.84"
change="0.94"
change_percent="7.9392%"
aroon_positive_momentum_days="67"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="419552"
Change_recent_avg="0.02"
Delta_recent_avg="0.91"
Variance_recent_avg="0.46"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_60"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="116"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0060.jpeg"
image_negative_thumbnail_id_2="107"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0069.jpeg"
image_neutral_thumbnail_id_1="547"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="622"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_positive_thumbnail_id_2="955"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
